According to new study, black patients in the U.S. with atrial fibrillation – an irregular heart rhythm – are less likely to receive the medications that would help prevent stroke, the most dangerous outcome of the condition, compared to whites and Hispanics.
“We found that African American patients were much less likely to receive the newer class of anticoagulant medications than whites, even after controlling for socioeconomic factors, such as income, education and insurance type,” said Dr. Utibe Essien of the University of Pittsburgh School of Medicine and core investigator at the Center for Health Equity and Research Promotion at the VA Pittsburgh Healthcare System in Pennsylvania.
No comments:
Post a Comment